Solara Active Pharma Sciences sells 100% stake in SeQuent Penems

26 Apr 2024 Evaluate

Solara Active Pharma Sciences has completed sale of 100% shareholding in SeQuent Penems to M/s. Symbio Generrics India on April 25, 2024. Hence, SeQuent Penems ceased to be a subsidiary of the Company. The board of directors of the company at its meeting held on March 25, 2024 approved the same.  

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

Solara Active Pharma Share Price

509.40 -24.55 (-4.60%)
25-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1786.85
Dr. Reddys Lab 1173.55
Cipla 1525.50
Lupin 2018.35
Zydus Lifesciences 859.10
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...